P.2.c.017 Creating a new clinically relevant endpoint in the PNB01 trial programme: the Early and Sustained Antidepressant Response (ESR)

Autor:	R. Van den Broeck, M.E. Thase, E. Buntinx, L. Haazen, D. de Chaffoy
Rok vydání:	2011
Předmět:	Pharmacology Psychiatry and Mental health medicine.medical_specialty Neurology business.industry Medicine Antidepressant Pharmacology (medical) Neurology (clinical) business Psychiatry Biological Psychiatry
Zdroj:	European Neuropsychopharmacology. 21:S392-S393
ISSN:	0924-977X
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7ef9b622b10591360a52dbc04e1fde72 https://doi.org/10.1016/s0924-977x(11)70631-9 Zobrazit plný text záznamu Full Text from ScienceDirect